You are here: Home » Reuters » News
Business Standard

Ex-drug executive Shkreli wins separate fraud trial


By Brendan Pierson(Reuters) - Martin Shkreli, the former drug company executive who drew public outcry when he raised the price of a life-saving drug by 5,000 percent, will be tried for securities fraud separately from a lawyer charged alongside him, a Brooklyn federal judge ruled Wednesday.Both Shkreli and lawyer Evan Greebel, who worked for Shkreli's former company Retrophin Inc, had asked that their case be split. U.S. prosecutors had sought to try the two men together on charges that they schemed to defraud investors in a hedge fund Shkreli controlled.Greebel's lawyer, Reed Brodsky, said ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, April 20 2017. 01:01 IST